Clinical Trial Update: A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study assessing whether a fixed-dose combination tablet of maraviroc with lamivudine/zidovudine is bioequivalent to taking maraviroc with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• Fixed-dose combination tablet (maraviroc + lamivudine/zidovudine)
• Maraviroc (maraviroc)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus I | Phase 1 | Status: COMPLETED